JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY VIRTUAL MEDICAL GRAND ROUNDS
12:30 - 1:30 PM
Join the Medical Grand Rounds on 
Microsoft Teams meeting.
Or call in (audio only) NEW: +1 438-799-0762, 502095193# Canada, Montreal, Phone Conference ID: 502 095 193#
The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Some Rounds were video recorded.
Medical Grand Rounds 2022-2023
May 29
Patient Blood Management and the Burden of Preoperative Anemia
Marc Bienz, MD
Transfusion Medicine Fellow at the University of Toronto
Educational Objectives:
- Understand Patient Blood Management (PBM)
- Present data on the impact of large-scale PBM Programs on the outcomes of surgical patients
- Discuss the most recent international and national recommendations on PBM
- Share my experience working in large-scale PBM programs in Toronto
Contact: Hans Knecht, MD, Chief, Division of Hematology, Tél 514-340-8222 poste 28434.
May 22
No Rounds - National Patriot Day / Victoria Day
May 15
Cardiovascular Hybrid Medical Grand Rounds
Radical Views on Atrial Fibrillation
Barbara Casadei, MD, DPhil FRCP FMedSci
Professor, Division of Cardiovascular Medicine
BHF Centre of Research Excellence, University of Oxford, UK
Educational Objectives:
- Target discovery approaches and clinical trial methodology
- Trials of perioperative statin therapy in patients undergoing cardiac surgery
- Evidence and mechanisms of postoperative acute kidney injury with statin therapy
Contact Person: Michael J Goldfarb, MD (Chair), 2023 Maurice McGregor CV Research Day Scientific Planning Committee
May 8
What’s New in the Treatment of an Old Disease (TB)
Dick Menzies, MD
Director, McGill International TB Centre & WHO Collaborating Centre in TB Research
Montreal Chest Institute, and Research Institute of the MUHC
Educational Objectives:
- Recent Canadian recommendations for treatment of TB Infection (TB preventive treatment)-what changed & why
- Latest and ongoing studies to shorten TB preventive treatment
- Latest studies in the treatment of drug-sensitive and drug-resistant TB and implications in Canada
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.
May 1
RESIDENTS CASE PRESENTATION
I. A Case of Immune-Checkpoint Inhibitor Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome
Cristina Pop, MD
Educational Objectives:
- Discuss prevalence of IRAEs, especially myocarditis
- Approach to diagnosis and treatment
- Discuss future treatment options and diagnostic tools
II. Acquired Hemophilia A: A Case-Based Approach to Bleeding Disorders
Josh Solomon, MD
Educational objectives:
- Approach and diagnosis of coagulopathies
- Understanding and interpreting the in-vitro work-up for coagulopathies
- Management of acquired factor inhibitors
Contact Person: Elise Levinoff, MD, Jewish General Hospital Site Program Director Core Internal Medicine Residency at McGill University, Tel. 514-340-8222 poste 24974.
April 24
Portrait of Rare Hereditary Diseases in the French-Canadian Founder Population of Saguenay-Lac-Saint-Jean
Tania Cruz Marino, M.D., Ph.D.
Medical Geneticist, Division of Medical Genetics, Departments of Specialized Medicine, MUHC & JGH,
Associate member, Medical Genetics Service, CIUSSS Saguenay-Lac-Saint-Jean
Assistant Professor, Department of Human Genetics, McGill University
Educational Objectives:
- To describe the clinical and molecular characteristics of hereditary diseases that are recurrent in the Saguenay-Lac-Saint-Jean region of Quebec
- To illustrate the carrier frequency of these diseases in Saguenay-Lac-Saint-Jean
- To recognize the role of provincial screening strategies in the prevention of these conditions
Contact Person: David Rosenblatt, MD, Division of Medical Genetics, Department of Specialized Medicine, Tel. 514-340-8222 ext. 23965.
April 17
Getting Dialysis Wrong- Newly Appreciated Ways we Hurt our Patients!
Chris McIntyre, MD, MBBS DM
Professor of Medicine, Medical Biophysics & Pediatrics
Robert Lindsay Chair, Dialysis Research and Innovation
Schulich School of Medicine and Dentistry, University of Western Ontario
Director, Lilibeth Caberto Kidney Clinical Research Unit (KCRU)
Educational Objectives:
- Appreciate that poor outcomes for dialysis patients is derived partly from the treatment itself
- Circulatory stress of the treatment causes multiple ischemic organ injuries
- Salt is a major uremic toxin and builds up in tissues causing further injury
- All of the above are amenable to novel interventions cast in an evolved understanding of the nature of the injury
Contact Person: Mark Lipman, MD, Chief, Division of Nephrology, Tel. 514-340-8229.
April 10
No Rounds - Easter Monday
April 3
Severe Mental Illness and Cardiovascular Disease
Michael Goldfarb, MD, MSc
Assistant Professor of Medicine, McGill University
Director, Quality of Care and Safety
Division of Cardiology, Jewish General Hospital
Educational Objectives:
- To describe the high burden of cardiovascular risk and mortality in people with severe mental illness
- To explore the factors driving poor cardiovascular outcomes in people with mental illness
- To highlight strategies to improve cardiovascular health in severe mental illness
Contact Person: Lawrence Rudski, MD, Chief, Division of Cardiology and Director, Azrieli Heart Center, Tel. 514-340-8222 ext. 22992.
March 27
Neoadjuvant Therapy for Operable Lung Cancer: Balancing Risks and Opportunities
Jonathan Spicer, MD, PhD FRCS
Associate Professor, Division of Thoracic Surgery
Director, McGill Thoracic Oncology Network
McGill University, Montreal General Hospital
Educational Objectives:
- Understand how to apply the latest data on precision systemic therapy for patients with operable early-stage lung cancer
- Explain the place of new therapies for resectable disease within the broader context of therapeutic options
- Describe important gaps in knowledge to broaden the scope of efficacy of a neoadjuvant therapeutic strategy
- Raise awareness of risks involved of misguided use of peri-adjuvant precision therapy
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-7900.
March 20
Low Molecular Weight Heparin and Cancer Mortality: Too Good to be True?
Marc Carrier, MD, MSc, FRCPC
Head of the Division of Hematology, The Ottawa Hospital
Professor, Faculty of Medicine, Department of Medicine
Senior Scientist in Clinical Epidemiology Program
The Ottawa Hospital Research Institute
Educational Objectives:
- To understand the mechanisms linking hypercoagulability and metastatic disease following cancer surgery
- To briefly discuss potential antimetastatic properties of low molecular weight heparin (LMWH)
- To review the results of the PERIOP-01 trial assessing the role of extended duration thromboprophylaxis with LMWH in patients undergoing localized colorectal cancer resection
Contact Person: Susan Kahn, MD, Division of Internal Medicine, Tel. 514-340-8222 extension 24667.
March 13
Lost in Translation: How Muscle-Bone Crosstalk is Affected in Osteosarcopenia
Gustavo Duque, MD, PhD, FRACP, FGSA
Professor, Faculty of Medicine
Dr. Joseph Kaufmann Chair in Geriatric Medicine
Principal Investigator - Bone, Muscle, and Geroscience Group
Research Institute of the McGill University Health Centre
Director - RUISSS McGill Centre of Excellence for Sustainable Health of Seniors/ Simone & Edouard Schouela
Editor-in-Chief Journal of Gerontology: Biological Sciences
Educational Objectives:
- To review the biological basis of muscle-bone crosstalk
- To discuss the alterations in muscle-bone crosstalk in osteosarcopenia
- To describe how targeting muscle-bone crosstalk offers new opportunities to diagnose and treat osteosarcopenia
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.
March 6
First Nations Vascular Health
Morris Schweitzer Ph.D., M.D., F.R.C.P. (C)
Director, Lipid Research and Management Clinic
Director, First Nations Vascular Health Program
Investigator, Lady Davis Institute
Associate Professor, Faculty of Medicine, McGill University
Educational Objectives:
- Understand that First Nations people in Canada are at an increased risk for cardiovascular disease, compared to non-First Nations people.
- Understand the contributing factors which result in the increased risk for cardiovascular disease.
- Understand how Telehealth can have a positive impact on health care delivery for remote communities.
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.
February 27
Bringing Vertical Integration to the Medical Inpatient
Karen Okrainec, MD MSc FRCPc
University Health Network and University of Toronto
General Internal Medicine
Toronto Western Hospital
Educational Objectives:
- To review challenges surrounding care transitions for both providers and patients.
- To highlight existing interventions and models of care being used in Canada and beyond.
- To discuss what’s hot with integrated models of care.
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, JGH - Tel. 514-340-7596.
February 20
De-frailing Older Adults with Cardiovascular Disease: The Tale of 3 JGH-Led Randomized Clinical Trials
Jonathan Afilalo, MD
Associate Professor of Medicine
Divisions of Cardiology and Epidemiology and Biostatistics
Azrieli Heart Center
Jewish General Hospital
Educational Objectives:
- To discuss the rationale for frailty as a therapeutic target
- To review the validated and novel tools to measure frailty in clinical practice
- To present the results of 3 recently completed de-frailing RCTs
Contact Person: Lawrence Rudski MD FRCPC FACC FASE, Professor of Medicine, McGill University, Director, Division of Cardiology, JGH - Tel. 514-340-8222 ext. 22992.
February 13
Immunotherapy for Environmental Allergies
Jesse Schwartz, MD, MSc, MPH, FRCPC
Director, Division of Allergy and Clinical Immunology
Jewish General Hospital
Educational Objectives:
- Learn about the indications, risks and benefits of immunotherapy for environmental allergies
Contact Person: Jesse Schwartz, MD, MSc, MPH, FRCPC, Director, Division of Allergy & Clinical Immunology, JGH - Tel. 514-340-8222 ext. 25454.
February 6
I. 70-Year-Old Male Presenting with Profound Pancytopenia and Bilateral Lower Leg Edema
Olivier Del Corpo, MD, MSc
Internal Medicine Second Year Medical Resident
McGill University and Jewish General Hospital
Educational Objectives:
- Approach to pancytopenia
- History of pernicious anemia
- Treatment for B12 deficiency
II. Primary Peritoneal Mesothelioma
Mohammed Alaithan, MD
Internal Medicine Second Year Medical Resident
McGill University and Jewish General Hospital
Educational Objectives:
- How rare is the disease
- Types and risk factors, how challenging is the diagnosis including imaging and other means of diagnosis
- Treatment options plus new treatments
Contact Person: Elise Levinoff, MD, Jewish General Hospital Site Program Director, Core Internal Medicine Residency at McGill University, Tel. 514-340-8222 poste 24974.
January 30
THIRTY FOURTH ANNUAL HUMANIZATION OF CARE AWARENESS PROGRAM ROUNDS
DIVERSITY, EQUITY AND INCLUSION IN HEALTHCARE
Christine Morin
Diversity, Equity, Inclusion and Belonging Officer,
Affiliated professor, Cegep du Vieux Montreal
Affiliated researcher, Research Center for Inclusion of people with disabilities (CRISPESH)
Educational Objectives:
- Build common understanding of basic terminology related to diversity, equity and inclusion
- Gain better understanding of the implication of diversity, equity and inclusion for healthcare practitioners and the delivery of superior quality care
Contact Person: Ms. Julie Sigwart, Administrative Coordinator, Humanization of Care Committee, 514-340-8222 Ext. 21924.
January 23
CUTANEOUS LYMPHOMA: A STEPWISE APPROACH
Kevin Pehr, MD
Associate Professor of Medicine, McGill University
Senior Investigator/Chercheur-Clinicien, Lady Davis Institute
Chief, Multidisciplinary Cutaneous Lymphoma Clinic
Division of Dermatology, Jewish General Hospital
Educational Objectives:
- Understand the range of cutaneous lymphomas
- Develop a stepwise approach to diagnosing cutaneous lymphoma
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 25065.4
January 16
In for the Long-Haul: The Hidden Pandemic of Post-Acute Sequelae Sars-Cov-2-Infection
Leighanne Parkes, MD
Assistant Professor of Medicine, McGill University
Staff, Division of Infectious Disease
Jewish General Hospital
Educational Objectives:
- Describe post-acute sequelae SARS-CoV-2 infection (PASC) as a new disease framework and the proposed mechanisms related to its development
- Describe an approach to the management of patients with PASC with respect to treatment and models of care
- Describe the barriers to treatment and prevention by tracing existing knowledge and care gaps and describe future avenues for research and system improvement
Contact Person: Karl Weiss, MD, Chief, Division of Infectious Diseases, Tel. 514-340-8222 ext. 28294.
January 9
DIABETES REMISSION- NEW CONCEPT, NEW GUIDELINE, & OUR RESET FOR REMISSION TRIAL
Kaberi Dasgupta, MD, MSc FRCPC
Professor of Medicine, McGill University
Divisions of Internal Medicine, Clinical Epidemiology, and Endocrinology and Metabolism, McGill University Health Centre
Director, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre
Educational Objectives:
- 1. To become familiar with the concept of diabetes remission in relationship to the DiRECT and DIADEM-I trials
- 2.To review the new Diabetes Canada remission guidelines and to whom they apply
- 3.To discuss our RESET for REMISSION trial, the combo of energy restriction and supervised exercise, and potential impacts
Contact Person: Rubin Becker, MD, Chief, Division of Internal Medicine, Tel. 514-340-7596.
January 2
NO ROUNDS
December 12
UPDATES IN MYASTHENIA GRAVIS: OUT WITH THE OLD, IN WITH THE NEW?
Dina Namiranian, MD, FRCPC, CSCN (EMG)
Assistant Professor
Department of Neurology and Neurosurgery, McGill University
Division of Neurology, Jewish General Hospital
Educational Objectives:
- Describe the current approach to both inpatient and outpatient management of myasthenia gravis
- Understand the roles of the complement and FcRN pathways in the disease
- Discuss emerging therapies and their potential use for symptom optimization
Contact Person: Jeffrey Minuk, MD, Chief, Division of Neurology, Tel. 514-340-8222 ext. 28770.
December 5
A PANDORA’S BOX CASE OF WEIGHT GAIN – REVISITING ECTOPIC ACTH SYNDROME
Vincent Larouche, MD, FRCPC
Assistant Professor of Medicine, McGill University
Staff, Division of Endocrinology
Jewish General Hospital
Educational Objectives:
- Review the different etiologies of ectopic ACTH (Cushing) syndrome
- Compare and contrast the diagnostic approach to Cushing disease (pituitary) vs ectopic ACTH syndrome
- Review the treatment modalities (surgical and medical) of ectopic ACTH syndrome
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976
November 28
SCHWARTZ ROUNDS: THE GREAT RESIGNATION: WHY I AM STILL HERE
Ernesto L. Schiffrin, C.M., MD, PhD, FRSC, FRCPC
Distinguished James McGill Professor and Associate Chair, Department of Medicine, McGill University
Physician-in-Chief, Jewish General Hospital
Mimi Israel, MD
Associate Professor, Department of Psychiatry, McGill University
Medical Director, Eating Disorders Program, Douglas Mental Health Institute
Montreal West Island Integrated University Health and Social Services Centre
Isabelle Caron, MSc N
Associate Director of Nursing, CIUSSS West-Central Montreal
Patricia Dobkin, PhD, OPQ
Associate Professor, Department of Medicine, McGill University
Faculty member, McGill Programs in Whole Person Care
Psychologist, Certified Mindfulness-Based Stress Reduction Teacher
Mark Smilovitch, MD, FRCPC
Associate Professor, Department of Medicine, McGill University
Cardiology Division, Royal Victoria Hospital, McGill University Health Centre
Faculty member, McGill Programs in Whole Person Care
Educational Objectives:
- Provide an opportunity to reflect on your experiences caring for patients and families
- Foster connection between colleagues
- Reconnect with your sense of purpose
Contact Person: Marc Rodger, MD, Chair, McGill Department of Medicine & Emily-Lea Churchill Smith, Research Assistant, McGill Department of Medicine, Wellness Office, Tel 514-934-4378
November 21
RELATIONSHIPS BETWEEN OBESITY AND INFLAMMATORY BOWEL DISEASES
Andrew Szilagyi, MD
Assistant Professor of Medicine, McGill University
Honorary Member, Division of Gastroenterology, Jewish General Hospital
Educational Objectives:
- Review definitions of obesity and its complications
- Describe possible intertwined pathogenesis and geo-epidemiology of obesity and IBD, pro-inflammatory factors as well as obesity on IBD risk, course and management
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.
November 14
I. 18F-FDG PET/CT FOR THE HEMATOLOGIST: A CASE-BASED APPROACH
Guillaume Chaussé, MD
Assistant Professor, Department of Radiology, McGill University
Staff, Department of Radiology, Division of Nuclear Medicine, CIUSSS du Nord-de-l'Île-de-Montréal
&
II. FDG PET/CT for infection - an Overview
Gad Abikhzer, MD
Assistant Professor, Department of Radiology, McGill University
Staff, Department of Radiology, Division of Nuclear Medicine, Jewish General Hospital
Educational Objectives:
I.
- Understand how PET scans are performed and how patients are prepared
- List the indications for 18F-FDG PET/CT newly diagnosed lymphoproliferative disorders
- Understand the usefulness of 18F-FDG PET/CT in follow-up of lymphoproliferative disorders
II.
- To understand the appropriate indications of FDG PET/CT in imaging of infectious diseases
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.
November 7
CANADIAN PATIENT SAFETY WEEK
Suicide Prevention: Review of Cases and Best Practices
- Mrs. Josée Bernier, RN, MSc, Quality, Risk Management and Patient Experience Advisor, CIUSSS West Central Montreal
- Mrs. Meg Hoodspith, RN, Clinical Activities Specialist, Emergency Department, Jewish General Hospital, CIUSSS West Central Montreal
- Mrs. Marie-Pier Long, RN, MS., Senior Nursing Advisor - Adult and Child Mental Health, DSI, CIUSSS West Central Montreal
- Dr Karl Looper, MD, Chief of Psychiatry, CIUSSS West Central Montreal
- Mrs. Jessica Rassy, RN, PhD, Professor, School of Nursing Sciences, Sherbrooke University
- Mrs. Annick Simard, TS MSW, Senior Clinical Advisor - Professional Practice, DRSM, CIUSSS West Central
- Dre Susan Wisebord, Psychiatrist, Head of the Mood and Anxiety Clinic and Emergency Follow Up Clinic
Educational Objectives:
- To understand the importance of suicide prevention
- To increase awareness of the CCOMTL policy and procedure on suicide prevention and the role of the suicide prevention committee
- To learn about the SECUrgence Protocol
Contact Person: Judith Tiao, M.Sc., Coordinator of Quality, Risk Management and User Experience, DQTEPE, ext. 27895.
October 31
PULMONARY CASES OF THE YEAR: CHALLENGING DIAGNOSTIC FEATS
Jason Agulnik, MD
Associate Professor of Medicine, McGill University
Chief, Division of Pulmonary, Jewish General Hospital
Andrew Hirsch, MD
Associate Professor of Medicine, McGill University
Division of Pulmonary, Jewish General Hospital
Nan Zhao, MD
Assistant Professor of Medicine, McGill University
Division of Pulmonary, Jewish General Hospital
Educational Objectives:
- Review 3 rare case presentations of pulmonary problems
- Learn about diagnostic pulmonary procedures that helped clarify diagnoses
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636.
October 24
UPDATE: BEST PRACTICE GUIDELINE FOR PAIN MANAGEMENT AND OPIOID-INDUCED RESPIRATORY DEPRESSION (OIRD) MONITORING
Céline Gélinas, PhD in Nursing
Professor, Ingram School of Nursing, McGill University
Investigator, Lady Davis Institute for Medical Research
Senior Researcher, Centre for Nursing Research, Jewish General Hospital
Educational Objectives:
At the end of this presentation, you will be able to describe:
- Key principles of best pain management practices
- Key principles of OIRD monitoring
Contact Person: Chantal Bastien, BSc.N, DSI, 514-340-8222 ext. 24816.
October 17
WORDS MATTER
David Eidelman, MDCM, FRCPC, FACP
Vice-Principal (Health Affairs) and Dean
Faculty of Medicine and Health Sciences
McGill University
Educational Objectives:
- What is meant by learner mistreatment?
- How does our situation compare with the literature?
- What can be done to improve?
Contact Person: Ms. Fern D Charles, Administrator, Office of the Vice-Principal and Dean, Faculty of Medicine and Health Sciences. Tel. 514-398-3524.
October 10
No Rounds - Thanksgiving
October 3
EIGHTH ANNUAL JGH DEPARTMENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM
I. MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA - INVESTIGATING NOVEL METHODS TO HELP BETTER PREDICT OUTCOMES
Rayan Kaedbey, MD
Assistant Professor of Medicine, McGill University
Division of Hematology, Jewish General Hospital
Educational Objectives:
- To review the definition of MRD and the different recognized methods
- To review the limitations of these methods
- To describe a novel MRD tool that will be investigated in transplant eligible patients at the JGH
II. ANTICOAGULATION STEWARDSHIP: DESCRIPTIVE ANALYSIS OF A NOVEL APPROACH TO APPROPRIATE ANTICOAGULANT PRESCRIPTION
Maral Koolian, MD, MSc
Assistant Professor of Medicine, McGill University
Division of Internal Medicine, Jewish General Hospital
Ryan Kerzner, B. Pharm., MSc
Pharmacist, Jewish General Hospital
Educational Objectives:
At the end of this session participants will be able to:
- Describe elements implicated in the development of a hospital-based anticoagulation stewardship program
- Synthetize results post-implementation of an anticoagulation stewardship program
- Identify potential limitations and barriers of an anticoagulation stewardship program
III. ASSOCIATION BETWEEN LEVOTHYROXINE USE AND PROGRESSIVE RENAL INSUFFICIENCY AMONG INDIVIDUALS WITH SUBCLINICAL HYPOTHYROIDISM
Oriana Yu, MD, MSc
Assistant Professor of Medicine, McGill University
Division of Endocrinology, Jewish General Hospital
Educational Objectives:
- To discuss the association between thyroid function and renal insufficiency
- To discuss study findings on whether treatment of subclinical hypothyroidism is associated with renal function
Contact Person: Vicky Tagalakis, MD, MSc, Division of Internal Medicine, Tel. 514-340-7596.
September 26
No Rounds - Rosh Hashanah
September 19
COMMUNICATING UNCERTAINTY IN CYTOPATHOLOGY AND SURGICAL PATHOLOGY REPORTS
Marc Pusztaszeri, MD
Associate Professor of Pathology, McGill University
Division of Pathology, Jewish General Hospital
&
Livia Florianova, MD
Assistant Professor of Pathology, McGill University
Division of Pathology, Jewish General Hospital
Educational Objectives:
- To become familiar with some of the limitations precluding a definitive diagnosis on cytology and on histology
- To become familiar with standardized reporting systems in diagnostic cytopathology
- To become familiar with various phrases/wording, commonly used to express different levels of diagnostic uncertainty in surgical pathology reports
Contact Person: Ms. Maureen Besley, Division of Pathology, Tel. 514-340-8274.
September 12
SPECIAL EVENT - MEET AND GREET THE RESIDENTS
Elise Levinoff, MD
Assistant Professor of Medicine, McGill University
Jewish General Hospital Site Program Director, Core Internal Medicine Residency, McGill University
Division of Geriatric Medicine
Jewish General Hospital
Contact Person: Elise Levinoff, MD, Jewish General Hospital Site Program Director, Core Internal Medicine Residency, McGill University, Tel. 514-340-8222 x 24974.